Gout Risk Factors, Outcomes in Dialysis Population Characterized
Some 15% of patients receiving dialysis in the United States have a gout diagnosis, according to a recent study.
All articles by Jody Charnow
COVID-19 Vaccine Immune Response in the Dialysis Population Quantified
A recent meta-analysis demonstrated that patients on dialysis are less likely to produce an immune response than those not on dialysis.
TURP Superior to Prostatic Artery Embolization at Improving BPH Symptoms
At 24 months after treatment for refractory BPH symptoms, patients who underwent transurethral resection of the prostate had more pronounced improvements in most functional outcomes compared with those treated with prostatic artery embolization, a study found.
Urinary Symptom Severity Affects Adherence to Diuretic Treatment
Adherence to diuretic therapy decreases as lower urinary tract symptoms increase in severity, according to a new study.
Avoiding Litigation by Knowing How to Deal With Angry Patients
Physicians can take steps to reduce their risk of being sued by having a low threshold for discharging angry patients from their practice and carefully documenting all discussions and interactions with these patients.
Earlier Surrogate for Survival After RP Relapse Possibly Identified
Castration-resistant prostate cancer correlates strongly with development of metastasis in men with PSA relapse following radical surgery for localized prostate cancer, but it occurs much sooner, and thus may provide an intermediate endpoint in clinical trials of new therapeutics.
HIFU Focal Ablation for PCa Offers Adequate Short-Term Cancer Control
In a study, men who underwent high-intensity focused ultrasound partial gland ablation for prostate cancer had excellent preservation of potency and continence.
Updated CKD Nutrition Guideline Released
The newest KDOQI guideline for renal nutrition, which took 5 years to develop, expands recommendations to include patients with all stages of chronic kidney disease.
The COVID-19 Pandemic Proves the World Is Small
The rapid spread of coronavirus disease 2019 (COVID- 19) caught the world by surprise. Whatever becomes the new normal, the United States will be a different country from what it was on March 13, when President Donald J. Trump declared a national emergency. At this writing on May 28, more than 100,000 people in the…
Carboplatin Possibly Beneficial in Refractory mCRPC
In a retrospective study, addition of carboplatin to chemotherapy regimens improved survival in men with metastatic castration-resistant prostate cancer whose disease progressed on second-generation hormone therapy.
- Loading...
Loading...
Next post in AUA 2020 Virtual Experience
Loading... 
Loading...